Pearls & Oy-sters: Adult-Onset Coats Plus: A Case of Leukoencephalopathy With Calcifications, a Tumefactive Brain

Catarina Serrão1, Romana Rodrigues1, Carla Leão Guerreiro2,3

  • 1Department of Neurosciences and Mental Health, Hospital de Santa Maria, ULS Santa Maria, Lisbon, Portugal.

Neurology
|September 15, 2025
PubMed

Insights

Coats plus, a rare genetic disorder, was diagnosed in a 46-year-old woman with adult-onset symptoms. This case expands the known clinical spectrum of Coats plus, highlighting its potential to mimic autoimmune conditions.

Area of Science:

  • Genetics and Molecular Biology
  • Neurology
  • Ophthalmology

Background:

  • Coats plus (Cp) is a rare, multisystemic genetic disorder.
  • Typically presents in early childhood with retinal vascular disease and leukoencephalopathy.
  • Often associated with defects in the CTC1 gene, inherited in an autosomal recessive manner.

Purpose of the Study:

  • To describe a unique case of adult-onset Coats plus.
  • To broaden the understanding of Cp's clinical presentation and genetic basis.
  • To highlight Cp as a differential diagnosis in patients with suspected autoimmune or neurovascular conditions.

Main Methods:

  • Case report of a 46-year-old female with progressive neurological and cognitive decline.
  • Comprehensive medical history, neurological examination, and brain MRI.
  • Genetic testing including Sanger sequencing of TREX1 and a multigene panel for neurologic diseases.

Main Results:

  • The patient presented with adult-onset Coats plus, mimicking an autoimmune disease.
  • Brain MRI showed asymmetric leukoencephalopathy with intracranial calcifications and a tumefactive lesion.
  • Genetic analysis revealed a homozygous pathogenic deletion in the CTC1 gene, confirming the diagnosis of Coats plus.

Conclusions:

  • This case expands the clinical spectrum of Coats plus to include milder adult-onset phenotypes.
  • Coats plus can mimic autoimmune disorders, necessitating careful genetic evaluation.
  • Highlights the importance of considering genetic disorders in complex adult-onset neurological presentations.